Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
The outcomes (O) measured were the proportions of study subjects diagnosed with any form of cancer
Authors relationships and activities KLJ has received research funding from Sanofi-Aventis and AstraZeneca and participated in advisory boards for Glyscend
While short-term preclinical studies suggest favorable safety, chronic administration effects on angiogenesis, growth factor signaling, and tissue remodeling over years of use remain unknown
Potential Benefits: Increased Energy Expenditure: Promotes higher resting metabolic rate and caloric burn, even in the absence of physical activity
US$ 25.91
US$ 23.88
US$ 28.35
US$ 20.02
US$ 20.05
US$ 20.92
US$ 24.32
